Occult pneumonia in infants with high fever without source: A prospective multicenter study

Pediatric Emergency Care

Volumn 26, Issue 7, 2010, Pages 470-474

  Mintegi, Santiago ^a   Benito, Javier ^a   Pijoan, Jose Ignacio ^a   Marañon, Rafael ^b   Peñalba, Ana ^b   Gonzalez, Andres ^c   Muñoz, Gisela ^c   Luaces, Carles ^d   Claret, Gemma ^d  

^a HOSPITAL DE CRUCES   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

fever; infants; leukocytosis; pneumonia

Indexed keywords

C REACTIVE PROTEIN; PNEUMOCOCCUS VACCINE;

AGE DISTRIBUTION; ARTICLE; BODY TEMPERATURE; CHILD; CLINICAL TRIAL; EMERGENCY WARD; FEMALE; HUMAN; INFANT; INFANT DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPHIL COUNT; OCCULT PNEUMONIA; PEDIATRICS; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; QUESTIONNAIRE; RADIOLOGIST; RISK ASSESSMENT; THORAX RADIOGRAPHY; BLOOD; COMORBIDITY; FEVER OF UNKNOWN ORIGIN; INCIDENCE; NEUTROPHIL;

C-REACTIVE PROTEIN; COMORBIDITY; FEMALE; FEVER OF UNKNOWN ORIGIN; HUMANS; INCIDENCE; INFANT; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PNEUMONIA; PROSPECTIVE STUDIES;

EID: 77954888240     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3181e582e4     Document Type: Article

References (23)

1. Mintegi S, Benito J, García S, et al. Demanda y asistencia en un servicio de urgencias hospitalario. An Pediatr (Barc). 2004;61: 156-161.
2. Crain EF, Bulas D, Bijur PE, et al. Is a chest radiograph necessary in the evaluation of every febrile infant less than 8 weeks of age? Pediatrics. 1991;88:821-824.
3. Losek JD, Kishaba RG, Berens RJ, et al. Indications for chest roentgenogram in the febrile young infant. Pediatr Emerg Care. 1989;5:149-152.
4. Bramson RT, Meyer TL, Silbiger ML, et al. The futility of the chest radiograph in the febrile infant without respiratory symptoms. Pediatrics. 1993;92(4):524-526.
5. Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med. 1999;33(2):166-173.
6. Herz AM, Greenhow TL, Alcantara J, et al. Changing epidemiology of outpatient bacteremia in 3-to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J. 2006;25(4):293-300.
7. Mintegi S, Benito J, González M, et al. Impact of the pneumococcal conjugate vaccine in the management of highly febrile children aged 6 to 24 months in an emergency department. Pediatr Emerg Care. 2006;22(8):566-569.
8. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002;21: 810-815.
9. Pratt A, Attia MW. Duration of fever and markers of serious bacterial infection in young febrile children. Pediatr Int. 2007;49(1):31-35.
10. Flood RG, Badik J, Aronoff SC. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children. Pediatr Infect Dis J. 2008;27(2):95-99.
11. Bramson RT, Meyer TL, Silbiger ML, et al. The futility of the chest radiograph in the febrile infant without respiratory symptoms. Pediatrics. 1993;92:524-526.
12. Murphy CG, van de Pol AC, Harper MB, et al. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med. 2007;14(3):243-249.
13. Zhou F, Kyaw MH, Shefer A, et al. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med. 2007;161(12):1162-1168.
14. Benito J, Mintegi S, Pocheville I, et al. Pneumococcal bacteremia among infants with fever without source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Pediatr Infect Dis J. 2007;26(8):667-671.
15. Capapé S, Luaces C, Garrido R, et al. Impacto de la vacunación neumocócica en el manejo del lactante con fiebre en relación al porcentaje de vacunación. An Pediatr (Barc). 2007;67(1):28-34.
16. Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369(9568):1179-1186.
17. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297(16):1784-1792.
18. Hsiao AL, Baker MD. Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr. 2005;17:56-61.
19. Andreola B, Bressan S, Callegaro S, et al. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. 2007;26:672-677.
20. Antonyrajah B, Mukundan D. Fever without apparent source on clinical examination. Curr Opin Pediatr. 2008;20:96-102.
21. Fernandez Lopez A, Luaces Cubells C, Garcia Garcia JJ, et al. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J. 2003;22:895-903.
22. Christ-Crain M, Müller B. Procalcitonin and pneumonia: is it a useful marker? Curr Infect Dis Rep. 2007;9(3):233-240.
23. Müller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007;7:10.